Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
The CX3C chemokine fractalkine...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
The CX3C chemokine fractalkine acts via an extracellular regulated kinase-dependent mechanism to induce human coronary artery smooth muscle cell proliferation
Manylion Llyfryddiaeth
Prif Awduron:
White, G
,
John, A
,
Greaves, D
Fformat:
Conference item
Cyhoeddwyd:
2007
Daliadau
Disgrifiad
Eitemau Tebyg
Dangos Staff
Eitemau Tebyg
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
gan: Lucas, A, et al.
Cyhoeddwyd: (2003)
THE CHEMOKINE FRACTALKINE (CX3CL1) HAS ANTI-APOPTOTIC AND PROLIFERATIVE EFFECTS ON PRIMARY HUMAN SMOOTH MUSCLE CELLS VIA EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALLING
gan: White, G, et al.
Cyhoeddwyd: (2009)
Fractalkine: one chemokine, many functions.
gan: White, G, et al.
Cyhoeddwyd: (2009)
Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators.
gan: White, G, et al.
Cyhoeddwyd: (2012)
An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis
gan: Fatemehsadat Pezeshkian, et al.
Cyhoeddwyd: (2024-10-01)